Artificial Intelligence
At 12.5% CAGR, Global Private Hospital Market Size & Share to Surpass USD 2000 Billion by 2028: Industry Trends & Forecast Report by Facts & Factors
NEW YORK, US, March 02, 2022 (GLOBE NEWSWIRE) — Facts and Factors published a new research report titled “Private Hospital Market By Category (Children’s Hospital, Multispecialty Hospitals, Acute Care Hospitals, and Specialty Hospitals), By Hospital Capacity (Large (>500 Beds), Medium (100 Beds – 500 Beds), Small (100 Beds)), By Location (Rural and Urban), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecast 2022 – 2028” in its research database.
“According to the latest research study, the demand of global Private Hospital Market size & share was worth around USD 820 billion in 2021 and is estimated to grow to about USD 2000 billion by 2028, with a compound annual growth rate (CAGR) of approximately 12.5% over the forecast period.”
The report analyzes the private hospital market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the private hospital market.
How big is the Private Hospital Market?
Private Hospital Market Overview:
Private hospitals are owned by either for-profit or non-profit organizations. It is often sponsored privately by payments made by patients for healthcare services, insurance, government agencies through national health insurance programs, and foreign delegations. Private hospitals are healthcare facilities that are privately funded. The private hospital market’s major sector is long-term healthcare. In different countries, the private healthcare industry varies in terms of size and responsibility.
The target market is significantly fragmented in many regions. Many small practices are owned by healthcare professionals in the private sector. Furthermore, the private hospital market is growing more commercial. In different countries, the private hospital market differs in size and responsibility. The private hospital market is severely fragmented in many regions. Many small practices owned by healthcare professionals exist in the private hospital market. Furthermore, the private hospital market is growing more commercial.
Get a Free Sample PDF of this Research Report for more Insights with Table of Content, Research Methodology and Graphs – https://www.fnfresearch.com/sample/private-hospital-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
- The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
- About 215+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
- Facts and Factors research methodology
(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)
Private Hospital Market Dynamics:
Drivers
- Increasing demand for medical services to drive global market growth
The utilization of private medical services is increasing as demand for medical services has increased. The growing elderly population enhanced reimbursement policies, and rising rates of chronic diseases are among the important aspects of the growth of the global private hospital market. Large-scale outsourcing of National Health Services and the advent of advanced medical technology and treatments are propelling the global market forward.
Also, the global market would benefit from more medical tourism and shorter treatment wait times. The need for diagnostic therapy and care is on the rise in the global private hospital market. However, the charges connected with private hospitals are a major factor limiting their growth. This is mostly due to high operational costs and service charges.
Opportunities
- Emerging scenario for medical tourism to bring growth opportunities for the global market
The global private hospital market would benefit from more medical tourism and shorter treatment wait times. The need for diagnostic therapy and care is on the rise in the global market. Further, the global players are getting into mergers & acquisitions that are either assisting them to expand their reach or enter the market. Also, the advent and implementation of budding technologies like using AI (Artificial Intelligence) in radiology for computer-aided diagnosis or using nuclear medicine for treating neurological diseases & oncology will further pave way for growth opportunities in the global market.
Prominent Market Players
- Toulon Hyères Private Hospital
- St Francis Foundation
- Deaconesses Croix Saint
- Apollo Hospitals Enterprise Ltd.
- Healthe Care
- Ramsay Health Care
- HCA Healthcare
- Fresenius SE & Co. KGaA
- Nuffield Health
- Fortis Healthcare Limited
- London Bridge Healthcare
- Life Healthcare
- Spire Healthcare Group Plc.
- MEOCLINIC Gmbh
- IASIS Healthcare
- Care UK
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/private-hospital-market
Private Hospital Market: COVID-19 Impact Analysis
The COVID-19 pandemic is anticipated to notably widen the increase in the global private hospital market. With the upward push in the number of COVID-19 patients, an increase in the wide variety of diagnostics and remedies for COVID-19 is predicted, which in turn is expected to bring about the production of large quantities of clinical waste. Furthermore, the management of in-patient and out-patient services in the course of a pandemic is of utmost importance, given social distancing. Moreover, hygiene care is crucial in combating COVID-19 conditions. As a result of COVID-19, healthcare facilities must provide care in the safest possible method for patients and healthcare professionals, according to the Centers for Disease Control and Prevention (CDC).
The second wave of COVID-19, on the other hand, had an impact on the private hospital market because patient visitation, both domestic and international, had dropped. Hospitals were forced to halt non-emergency, outdoor patient department (OPD), and indoor patient department (IPD) services due to high infection rates and lockdowns. As a result of travel restrictions, medical tourism had also declined.
Despite the initial drop in visitation, signs of patient recovery and modified lockdown regulations resulted in a rise in hospital occupancy rates.
Key Insights from Primary:
- As per the analysis shared by our primary respondents, the global private hospital market is estimated to grow at a CAGR of 12.5% during the forecast period.
- Through the primary research, it was established that the Private Hospital market was valued at around USD 820 billion in 2021and is predicted to cross over USD 2000 billion by 2028.
- By 2028, the acute care hospital segment is expected to generate over USD 950 billion in revenue.
- Based on the Hospital capacity segment, the medium bed size segment is likely to generate almost USD 1,200 billion in revenue during the forecast period.
- On the basis of region, North America leads the global private hospital market.
Key questions answered in this report:
- What is the market size and growth rate forecast for Private Hospital Industry?
- What are the main driving factors propelling the Private Hospital Market forward?
- What are the leading companies in the Private Hospital Industry?
- What segments does the Private Hospital Market cover?
- How can I receive a free copy of the Private Hospital Market sample report and company profiles?
Inquire before buying this Research Report – https://www.fnfresearch.com/inquiry/private-hospital-market
Report Scope
| Report Attribute | Details |
| Market Size in 2021 | USD 820 Billion |
| Projected Market Size in 2028 | USD 2000 Billion |
| CAGR Growth Rate | 12.5% CAGR |
| Base Year | 2021 |
| Forecast Years | 2022-2028 |
| Key Market Players | Toulon Hyères Private Hospital, St Francis Foundation, Deaconesses Croix Saint, Apollo Hospitals Enterprise Ltd., Healthe Care, Ramsay Health Care, HCA Healthcare, Fresenius SE & Co. KGaA, Nuffield Health, Fortis Healthcare Limited, London Bridge Healthcare, Life Healthcare, Spire Healthcare Group Plc., MEOCLINIC Gmbh, IASIS Healthcare, and Care UK., among others |
| Key Segment | By Category, By Hospital Capacity, By Location, and By Region |
| Major Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
| Purchase Options | Request customized purchase options to meet your research needs. Explore purchase options |
Private Hospital Market: Segmentation Analysis
The global private hospital market is segregated based on category, hospital capacity, location, and region. Based on category, the global market is distinguished into children’s hospitals, multispecialty hospitals, acute care hospitals, and specialty hospitals. The acute care hospitals segment dominates the market.
Based on hospital capacity, the market is bifurcated into large, medium, and small. The medium size hospitals segment is expected to lead over the forecast period. As per location, the market is segmented into rural and urban, the latter contributes massively towards the overall private hospital market share.
Request for Customization on this Report as per your requirements – https://www.fnfresearch.com/customization/private-hospital-market
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customizing your report.)
Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?
Email Directly Here with Detail Information: [email protected]
Regional Dominance:
- North America leads the global private hospital market
North America leads the global private hospital market because of its vast aging population and rising rates of lifestyle-related disorders. During the forecast period, the global market is predicted to rise at a rapid pace, with Asia leading the way, followed by Europe. India and China are predicted to be the Asia Pacific region’s fastest-expanding private hospital markets.
Large patient pools increased healthcare knowledge, and increased healthcare costs are some of the primary driving reasons for the private hospital market in emerging countries. Furthermore, in developing countries, the government is unable to address healthcare needs due to a lack of resources.
Browse the full “Private Hospital Market By Category (Children’s Hospital, Multispecialty Hospitals, Acute Care Hospitals, and Specialty Hospitals), By Hospital Capacity (Large (>500 Beds), Medium (100 Beds – 500 Beds), Small (100 Beds)), By Location (Rural and Urban), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecast 2022 – 2028.” Report at https://www.fnfresearch.com/private-hospital-market
The global private hospital market is segmented as follows:
By Category Segmentation Analysis
- Children’s Hospital
- Multispecialty Hospitals
- Acute care Hospitals
- Specialty Hospitals
By Hospital Capacity Segmentation Analysis
- Large (>500 beds)
- Medium (100 beds-500 beds)
- Small (100 beds)
By Location Segmentation Analysis
- Rural
- Urban
Key Offerings:
- Market Size, Share & Forecast by Revenue | 2022−2028
- Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
- Market Segmentation – A detailed analysis by Category, Hospital Capacity, Location, and Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Request Your Free Sample Report of the Global Private Hospital Market @ https://www.fnfresearch.com/sample/private-hospital-market
Recent Developments
- September 2021 – With the opening of the first-of-its-kind specialized Bone Marrow Unit in Central Mumbai, Fortis Hospital, the renowned multi-specialty tertiary care hospital, is ready to shape the future in bone marrow transplants.
- November 2021 – Quirónsalud, one of the largest private hospital firms in Spain and a subsidiary of Fresenius Helios, has agreed to acquire Clínica Clofán, and Centro Oncológico de Antioquia (COA), strengthening the company’s position in Colombia.
Browse Other Related Research Reports from Facts & Factors
K-12 Private Education Market: https://www.fnfresearch.com/k-12-private-education-market
Private Tutoring Market: https://www.fnfresearch.com/private-tutoring-market-by-type-online-and-blended-170
Hospital Outsourcing Market: https://www.fnfresearch.com/hospital-outsourcing-market
Hospital Mobile X-Ray Market: https://www.fnfresearch.com/hospital-mobile-x-ray-market
Private Label Food and Beverages Market: https://www.fnfresearch.com/private-label-food-and-beverages-market-by-product-773
Medical Device Market: https://www.fnfresearch.com/medical-device-market
About Facts & Factors:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us on Twitter: https://twitter.com/fnfresearch
Follow Us on Facebook: https://www.facebook.com/factsandfactors/
Contact Us:
Sanu Thomas
USA: +1 347 690-0211
United Kingdom: +44 2032 894158
Japan: +81 50 5806 9039
India: +91 96043 17127
Email: [email protected]
Web: https://www.fnfresearch.com
Blog: http://fnfnewsblog.com
Artificial Intelligence
THE 2024 GLOBAL EXPLORATION SUMMIT IS ANNOUNCED AT THE 120th EXPLORERS CLUB ANNUAL GALA IN NEW YORK
Porto and Terceira Island to Host the ‘Davos of Exploration’ – The GLEX Summit
NEW YORK, April 24, 2024 /PRNewswire/ — The Explorers Club and Expanding World, are thrilled to announce the fifth edition of The GLEX Summit, known as the ‘Davos of Exploration,’ set to take place from June 15 to 19 on Porto city and Terceira Island in the Azores, Portugal.
This year, Porto will Ignite the summit, followed by two days of discussions and exploration in the historic city of Angra do Heroísmo on Terceira Island. From the depths of the oceans to new space missions, the power and future of exploration will be explored in these two World Heritage cities, deeply connected to the history of exploration.
The 2024 GLEX Summit will revolve around the latest discoveries and groundbreaking missions shaping the future of our planet. Highlights of the summit include the Artemis mission, which plans to send astronauts back to the moon for the first time since 1972, and the role of Space and the Oceans in researching and mitigating the effects of climate change. Notable sessions will also delve into the unfortunate incident of the submersible implosion that took place on Titan and the recording of an episode of the BBC’s acclaimed science comedy show ‘The Infinite Monkey Cage,’ hosted by physicist Brian Cox and comedian Robin Ince.
This prestigious event will bring together over three dozen explorer and scientist legends from around the world. Confirmed physicist and researcher Brian Cox, NASA Chief Scientist James Garvin, Aquanaut Fabien Cousteau, Oceanographer David Gallo, Cosmonaut Mike Massimino, Nasa ISS CapCom Tess Caswell, among many others global Explorers and Scientists.
For further inquiries about The GLEX Summit and press accreditation, please contact:
Marco Barbosa [email protected], +351917345744
Photo: https://mma.prnewswire.com/media/2395857/GLEX_Summit.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/the-2024-global-exploration-summit-is-announced-at-the-120th-explorers-club-annual-gala-in-new-york-302125563.html
Hillstone Networks delivers advanced Microsegmentation across different verticals..
SANTA CLARA, Calif., April 24, 2024 /PRNewswire/ — Hillstone Networks, a leading provider of cybersecurity solutions, has been included in the Forrester Microsegmentation Solutions Landscape, Q2 2024 report. The report offers an overview of the Microsegmentation market, focused on the vendors who deliver solutions for protection of critical resources, combating ransomware, and contributing to compliance adherence. The report provides security professionals a snapshot of these named vendors, considering factors such as size, geographic focus, and use cases to select the most suitable option for their targeted use cases or needs.
In the Landscape Report, Forrester states that “Zero Trust is all about replacing bodies of implicit trust with explicit policy. In physical and virtual networks, the application of this principle is referred to as microsegmentation…. [It] was one of the first true Zero Trust technologies developed after Forrester published the initial Zero Trust reports.”
Forrester states in the report that the main trend is “organizations are finally getting serious about Zero Trust. Some, proactively, are implementing microsegmentation as part of a Zero Trust strategy or initiative. Others are implementing it because they got hit by ransomware and are trying to avoid it again. But all of them are doing Zero Trust with microsegmentation.”
“Being recognized as a vendor in the Microsegmentation solution landscape underscores for us the pivotal role our technology plays in safeguarding critical assets and thwarting ransomware threats. We believe it reaffirms our commitment to providing cutting-edge security measures built on an innovative and AI-powered platform that help our customers defend against evolving cyber risks, ensuring resilience and trust,” states Tim Liu, CTO and Co-founder at Hillstone Networks.
Hillstone’s Microsegmentation solution provides the following key benefits:
Advanced and extensive Microsegmentation for physical servers, virtual machines, cloud hosts, and containers, seamlessly compatible with multiple platforms.Comprehensive, integrated Layer 4 to 7 security and malware features (Next Generation Firewall, Intrusion Prevention System, AntiVirus, URL filtering, DDoS, and bot defense), and complete vulnerability management across the entire application lifecycle.Distributed architecture for easy scaling and portability.Centralized and comprehensive visibility to reduce gaps in the threat surface.Learn more about Hillstone Networks solutions here.
About Hillstone Networks
Hillstone Networks’ Integrative Cybersecurity approach is based on a visionary, AI-powered, and accessible platform, delivering coverage, control, and consolidation to secure over 28,000 global enterprises.
Media ContactZeyao Hu+1 [email protected]
Logo – https://mma.prnewswire.com/media/765968/Hillstone_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/hillstone-networks-is-named-in-microsegmentation-solutions-landscape-report-302125530.html
Artificial Intelligence
Tetra Pharm Technologies and Glysious Announce Collaboration to Develop Transdermal Combination Drugs Targeting the Endocannabinoid System
The collaboration brings together Tetra Pharm Technologies’ expertise in enabling technology with Glysious’ proprietary transdermal drug delivery system, renowned for its effectiveness, comfort, and convenience.
COPENHAGEN, Denmark, April 24, 2024 /PRNewswire/ — Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies’ pipeline candidates. The joint invention aims to revolutionize transdermal release of “difficult-to-formulate” compounds targeting the endocannabinoid system.
Tetra Pharm Technologies has focused intensively on formulation expertise, that is, how the molecules are effectively integrated with a drug delivery system to reach their desired targets. Glysious has worked rigorously on the development of an adhesive patch for transdermal drug delivery since the company’s incorporation in 2020.
“The Glysious technology enables precision, sustained dosing, and allows for a high drug load and effective emptying of patches. The transdermal patches remain in place and are very comfortable and convenient to use, resulting in improved patient compliance. However, we have identified challenges with standard formulation strategies, not providing acceptable drug release due to shortcomings of the formulation matrix”, says Professor, Dr.Techn. Anne Ladegaard Skov, Chief Scientific Officer, Glysious.
Back in 2023 Glysious and Tetra Pharm Technologies performed early in-vitro feasibility tests, integrating Tetra Pharma Technologies’ proprietary enabling technology for delivery of poorly soluble compounds with Glysious’ patch.
Dr. Morten Allesø, Chief Scientific Officer, Tetra Pharm Technologies, adds: “Although both parties were aware of the uniqueness of our respective technologies, we were positively surprised to find a five-fold increase in performance of our combination product compared to conventional formulation technologies. This is truly remarkable, and we consider it our shared obligation to further advance this technology to the benefit of the patients.”
The objectives of the collaboration include conducting comprehensive in-vitro and in-vivo studies to evaluate the performance and efficacy of the combined drug delivery system. Additionally, Tetra Pharm Technologies and Glysious plan to pursue a common patent for the joint invention, ensuring that their innovative technology remains protected and exclusive.
“We are excited to collaborate with the innovative team in Tetra Pharm Technologies on this transdermal drug delivery system paving the way for commercialization and scaling of the Glysious technology within the pharma segment”, says Stina Bjerg Nielsen, Chief Executive Officer, Glysious.
Martin Rose, Chief Executive Officer, Tetra Pharm Technologies, concludes: “The collaboration represents a unique opportunity to harness the synergies between our respective technologies. By combining our expertise, we aim to develop a transdermal drug delivery system that offers superior efficacy, convenience, and patient compliance, supporting several of our pipeline programs”.
As part of the collaboration, the partners will exchange expertise, knowledge, and resources. In addition, Tetra Pharm Technologies and Glysious will conduct joint research, experiments, and tests as required for the development of a joint patent. The scope of the collaboration is focused on disease indications such as pain, sleep disorders, and appetite regulation.
About Tetra Pharm Technologies
Tetra Pharm Technologies is a Danish biopharmaceutical company established in 2018 with a vision to be a leader in research and development of pharmaceutical drugs for the treatment of diseases related to the endocannabinoid system. For more information, please visit www.tetrapharm.eu
About Glysious
Glysious is a Danish medtech company, incorporated in 2020, that develops patches, creams, spray, and foams with controlled release of active ingredients for cosmetics and life science applications. For more information, please visit www.glysious.com
For further informationJacob SchlundtChief Marketing OfficerTetra Pharm [email protected]+45 51976225
Stina Bjerg NielsenChief Executive [email protected]+45 3053 5393
Photo – https://mma.prnewswire.com/media/2393210/Tetra_Pharm_Technologies_Deal.jpgLogo – https://mma.prnewswire.com/media/1988863/Tetra_Pharm_Technologies_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/tetra-pharm-technologies-and-glysious-announce-collaboration-to-develop-transdermal-combination-drugs-targeting-the-endocannabinoid-system-302123136.html
-
Artificial Intelligence7 days agoHuawei Introduces AI Technologies to Accelerate Network Transformation Towards All Intelligence in the Net5.5G Era
-
Uncategorized5 days agoGenerative AI gold rush drives IT spending — with payoff in question
-
Uncategorized5 days ago
Do underwriters trust artificial intelligence?
-
Uncategorized5 days ago
Hans Jonas on Responsibility in the Age of Artificial Intelligence
-
Uncategorized5 days ago
Meta AI Assistant Adds Website, Expands Beyond US
-
Artificial Intelligence5 days agoFree Your Hands, QIDI Vida Smart AR Glasses Lead the Way in New Sports Experience.
-
Uncategorized5 days ago
Can artificial intelligence reduce vehicle time to market?
-
Uncategorized5 days ago
The Ottawa Hospital doctors to try AI for patient notes
